Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.
Study indicates the benefits of stopping aspirin in heart attack patients

Study indicates the benefits of stopping aspirin in heart attack patients

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility

Drug coated balloons are as good as stent implants for treating small blocked arteries

Drug coated balloons are as good as stent implants for treating small blocked arteries

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

Antiplatelet monotherapy appears to be safer but does not reduce risk of heart attack

New clinical trial shows safety and efficacy of second generation drug-eluting stents

New clinical trial shows safety and efficacy of second generation drug-eluting stents

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Expert encourages cardiologists to continue using conventional drug-eluting stents

Expert encourages cardiologists to continue using conventional drug-eluting stents

New app helps heart patients with drug-eluting stents adhere to medications, study finds

New app helps heart patients with drug-eluting stents adhere to medications, study finds

Stents can be as effective as surgery for many patients with left main coronary artery disease

Stents can be as effective as surgery for many patients with left main coronary artery disease

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy